Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Int Immunopharmacol. 2013 Nov 13;18(1):35–42. doi: 10.1016/j.intimp.2013.10.026

FIGURE 1. Effect of allosamidin on oral OVA induced eosinophilic inflammation in esophagus.

FIGURE 1

The esophagus from non-OVA challenged (Fig 1A) and OVA challenged (Fig 1B) were immunostained with an anti-MBP Ab. The number of MBP+ eosinophils in the esophagus were quantitated per mm2 of epithelium (Fig 1C), per mm2 of lamina propria (Fig 1D), and per mm2 of muscle layer (Fig 1E) in three different groups (no OVA; OVA+ diluent; OVA+ allosamidin)(n=12 mice/group).